BioNTech SE - ADR Stock News

German drugmaker BioNTech has agreed to acquire Chinese biotech company Biotheus to support its oncology strategy and gain full global rights to the bispecific antibody candidate BNT327, it said on Wednesday.

MAINZ, Germany, November 13, 2024 (GLOBE NEWSWIRE) --  BioNTech SE  (Nasdaq: BNTX, “BioNTech”) and Biotheus (“Biotheus”) today announced the signing of a definitive agreement for the acquisition of Biotheus, a clinical-stage biotechnology company dedicated to the discovery and development of novel antibodies to address unmet medical needs of patients with oncological or inflammatory diseases.

Das mit seinem Corona-Impfstoff bekannt gewordene Mainzer Unternehmen Biontech US09075V1026 will die Entwicklung von Krebsmedikamenten mit einer millionenschweren Übernahme einer chinesischen Firma weiter vorantreiben.

Die US-Investmentbank Goldman Sachs hat Biontech US09075V1026 von "Neutral" auf "Buy" hochgestuft und das Kursziel von 90 auf 137 US-Dollar angehoben.

Die US-Investmentbank Goldman Sachs hat Biontech US09075V1026 von "Neutral" auf "Buy" hochgestuft und das Kursziel von 90 auf 137 US-Dollar angehoben.

BioNTech SE's stock saw a spike in September due to positive data from Summit Therapeutics' ivonescimab, which has a similar mechanism to BioNTech's BNT327. BioNTech's Q3 earnings showed improved revenues and profit, largely driven by its COVID-19 vaccine, Comirnaty, which remains a significant revenue source. Despite the potential in oncology, BNTX's current valuation is high relative to its n...

Investors are worried about what a Trump administration means for hospital operators and vaccine makers, but are optimistic about the fate of Medicare Advantage plan providers.

BioNTech SE (NASDAQ:BNTX ) Q3 2024 Earnings Conference Call November 4, 2024 8:00 AM ET Company Participants Michael Horowicz - Director, Investor Relations Ugur Sahin - Chief Executive Officer & Co-Founder Özlem Türeci - Chief Medical Officer & Co-Founder Jens Holstein - Chief Financial Officer Ryan Richardson - Chief Strategy Officer Conference Call Participants Tazeen Ahmad - Bank of America...